创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology qPCR Assay Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-17 16:18
  • Views:

(Summary description)On the road of tumor drug development, accurate and efficient detection technology is crucial for the evaluation of drug effects, research on mechanism of action and safety assurance. InnoModels Biotechnology (Beijing) Co., Ltd. provides a one-stop efficient and precise solution for tumor drug discovery and development with its unique qPCR assay platform.

InnoModels Biotechnology qPCR Assay Platform

(Summary description)On the road of tumor drug development, accurate and efficient detection technology is crucial for the evaluation of drug effects, research on mechanism of action and safety assurance. InnoModels Biotechnology (Beijing) Co., Ltd. provides a one-stop efficient and precise solution for tumor drug discovery and development with its unique qPCR assay platform.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-07-17 16:18
  • Views:
Information

On the road of tumor drug development, accurate and efficient detection technology is crucial for the evaluation of drug effects, research on mechanism of action and safety assurance. InnoModels Biotechnology (Beijing) Co., Ltd. provides a one-stop efficient and precise solution for tumor drug discovery and development with its unique qPCR assay platform.
Platform Overview:
InnoModels Bio's qPCR platform, based on real-time quantitative polymerase chain reaction (qPCR) technology, is a highly sensitive and accurate nucleic acid detection method. The platform not only provides researchers with an accurate assessment of target gene expression and drug effects, but also demonstrates significant advantages in the drug development process.
Platform features:
1. Highly sensitive and precise: The qPCR platform is capable of detecting extremely low levels of target nucleic acids and providing accurate quantitative data. This feature enables researchers to more accurately assess the activity and effects of drugs, thus accelerating the drug development process.
2. Specialized design: The platform is specifically optimized for the characteristics of nucleic acid-coupled drugs and mRNA drugs to ensure efficient and specific detection. This makes the platform more relevant and useful in oncology drug discovery.
3. High throughput: The platform supports simultaneous detection of multiple samples, which greatly improves detection efficiency. Researchers can complete the testing of a large number of samples in a short period of time, further shortening the drug development cycle.
4. Flexibility: The platform can be customized according to different research needs to meet the diverse experimental needs of researchers. Whether it is gene expression analysis, drug effect evaluation or mechanism research, the platform can provide personalized solutions.

 


Applications in tumor drug development:
1. Drug effect assessment: By measuring the expression of target genes, researchers can accurately assess the activity and effect of drugs, providing powerful support for drug screening and optimization.
2. Mechanism study: In-depth understanding of the mechanism of action of nucleic acid-coupled drugs and mRNA drugs provides direction for drug optimization. The data provided by the platform can reveal the interaction relationship between drugs and targets, providing scientific basis for drug design.
3. Safety assessment: By detecting the expression of relevant marker genes, researchers can assess the potential toxicity and safety of drugs. This helps to identify and solve potential safety issues at the early stage of drug development and reduce the risk of drug development.
Cutting-edge technology and expert support:
InnoModels Bio's qPCR assay platform utilizes the latest qPCR technology to ensure that researchers get the best results. In addition, the company has an expert team of experienced scientists to provide researchers with strong technical support and one-stop services. From sample processing to data analysis, the company can provide researchers with all-round support.
In conclusion, InnoModels' qPCR assay platform demonstrates significant advantages in oncology drug discovery and development with its highly sensitive and precise, specialized design, high throughput and flexibility. The platform not only improves the efficiency and quality of drug discovery and development, but also provides researchers with more experimental options and data support. In the future, with the deepening and development of tumor drug R&D, the qPCR assay platform of InnoModels Biotechnology will continue to play an important role and contribute to tumor drug R&D.

Keyword:

With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
In the vast field of drug discovery and life science research, InnoModels Biotechnology (Beijing) Co., Ltd. is gradually becoming a leader in the industry with its IC50 platform. The platform not only integrates advanced detection technologies, abundant cell resources and strict quality control system, but also provides researchers with efficient and reliable experimental solutions through continuous innovation and optimization.
In the field of life sciences, every leap in technology leads to deeper research and medical advances. InnoModels Biotechnology (Beijing) Co., Ltd, with its innovative 3D organoid platform, is providing scientists with an unprecedented research tool, which greatly promotes drug research and development and the exploration of disease mechanisms
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
Previous page
1
2
42
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司